by Dr Harikiran Chekuri | Apr 6, 2026 | Blog
Retatrutide injections currently have no fixed commercial price in India because the drug has not yet received regulatory approval for retail sale. Cost is determined by the source of the compound, the dosage required, how many injections the protocol involves, and...
by Dr Harikiran Chekuri | Apr 6, 2026 | Blog
Retatrutide (reta) peptide causes side effects, primarily mild-to-moderate gastrointestinal issues like nausea, diarrhea, vomiting, and constipation. These are most common during initial dose escalation. While generally safe in trials, potential less common side...
by Dr Harikiran Chekuri | Apr 6, 2026 | Blog
No, retatrutide is not commercially available in India as an approved drug yet. It is currently in Phase 3 clinical trials globally and has not received regulatory approval from India’s CDSCO or the US FDA for commercial sale as of now. However,...
by Dr Harikiran Chekuri | Apr 6, 2026 | Blog
No, peptides are not steroids. They are distinct molecules with different structures and functions: peptides are short chains of amino acids that signal natural body processes, while anabolic steroids are synthetic lipid-derived hormones, often mimicking testosterone....
by Dr Harikiran Chekuri | Apr 4, 2026 | Blog
The legality question around peptide treatment is one that genuinely needs a nuanced answer because it’s not the same across every compound or every setting. Some peptides are established pharmaceutical drugs used in medicine for decades and prescribed freely by...